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In Vivo Molecular Characterization of Abdominal Aortic Aneurysms
Using Fibrin-Speciﬁc Magnetic Resonance Imaging
Rene M. Botnar, PhD; Julia Brangsch, VMD; Carolin Reimann, VMD; Christian H. P. Janssen, MD; Reza Razavi, MD; Bernd Hamm, MD;
Marcus R. Makowski, MD, PhD
Background-—The incidence of abdominal aortic aneurysms (AAAs) will signiﬁcantly increase during the next decade. Novel
biomarkers, besides diameter, are needed for a better characterization of aneurysms and the estimation of the risk of rupture.
Fibrin is a key protein in the formation of focal hematoma associated with the dissection of the aortic wall and the development of
larger thrombi during the progression of AAAs. This study evaluated the potential of a ﬁbrin-speciﬁc magnetic resonance (MR)
probe for the in vivo characterization of the different stages of AAAs.
Methods and Results-—AAAs spontaneously developed in ApoE/ mice following the infusion of angiotensin-II (Ang-II, 1 lg/
kg1per minute). An established ﬁbrin-speciﬁc molecular MR probe (EP2104R, 10 lmol/kg1) was administered after 1 to 4
weeks following Ang-II infusion (n=8 per group). All imaging experiments were performed on a clinical 3T Achieva MR system with a
microscopy coil (Philips Healthcare, Netherlands). The development of AAA-associated ﬁbrin-rich hematoma and thrombi was
assessed. The high signal generated by the ﬁbrin probe enabled high-resolution MR imaging for an accurate assessment and
quantiﬁcation of the relative ﬁbrin composition of focal hematoma and thrombi. Contrast-to-noise-ratios (CNRs) and R1-relaxation
rates following the administration of the ﬁbrin probe were in good agreement with ex vivo immunohistomorphometry (R2=0.83 and
0.85) and gadolinium concentrations determined by inductively coupled plasma mass spectroscopy (R2=0.78 and 0.72).
Conclusions-—The ﬁbrin-speciﬁc molecular MR probe allowed the delineation and quantiﬁcation of changes in ﬁbrin content in
early and advanced AAAs. Fibrin MRI could provide a novel in vivo biomarker to improve the risk stratiﬁcation of patients with aortic
aneurysms. ( J Am Heart Assoc.2018;7:e007909. DOI: 10.1161/JAHA.117.007909)
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D iseases of the cardiovascular system still represent themain cause of death in Western societies. In this group,
speciﬁcally, diseases of the aorta demonstrate an increase in
incidence.1,2 In the group of cardiovascular diseases, the
rupture of aortic aneurysms currently represents the third most
common cause of sudden death, with myocardial infarction and
stroke representing numbers one and two. In the general
population older than 50 years, the incidence of abdominal
aortic aneurysms (AAAs) is 5%. Currently, more than 70 000
interventions and operations are performed for the treatment of
AAAs in the United States.3,4 Even though AAAs represent a
relevant disease, the exact pathophysiological mechanisms
leading to their development are still unknown. Therefore, a
large number of aneurysms are classiﬁed to have a nonspeciﬁc
cause.5 For only a limited number of aneurysms, deﬁnite causes
are known and can be deﬁned. These include infections,
connective tissue disorders (eg, Marfan disease) and trauma.
Independent of the cause, it is thought that the rupture of the
elastic laminae in the tunicamedia leads to the dissection of the
aortic wall. This subsequently leads to a progressive dilation of
the aortic lumen. If these processes remain unrecognized and
untreated, an aortic rupture with fatal implications for the
patient can be the consequence.6
For the tensile strength of the aortic wall, the extracellular
matrix plays the most important role. The highest expressed
proteins in the tunica media are collagen and elastic ﬁbers.
They contribute most to the tensile strength to withstand the
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arterial pulsation and high intravascular pressure.7 Most
postmortem histopathologic studies agree that the break-
down of collagen and elastic ﬁbers in the aortic wall leads to a
weakening and progressive dilation of the aorta, resulting in
the development of an aneurysm.8 Speciﬁcally, the rupture of
elastic laminae in the tunicamedia leads to an aortic dissection.
This results in the activation of the blood-clotting cascade, the
accumulation of ﬁbrin at the rupture site with the development
of a focal ﬁbrin-rich hematoma in the aortic wall.9 If the
aneurysm continues to increase in size, a large ﬁbrin-rich
thrombus is formed. Following that, the aneurysmal tissue
matures and the ﬁbrin-rich matrix is increasingly replaced and
stabilized by other extracellular matrix proteins, including
collagen and elastin.9–11 It is thought that the balance between
the synthesis and degradation of these extracellular matrix
proteins in the ruptured aortic wall and thrombus determines
the further progression and outcome of AAAs.9 In this context,
the D-dimer has been recently proposed as the most promising
novel biomarker for an improved characterization of aortic
aneurysms in a clinical setting.12–14 The D-dimer represents a
ﬁbrin fragment, which is formed during the blood-clotting
cascade following aortic dissection. Its concentration corre-
lates with the development of a focal hematoma and thrombus
size. This underlines the important role that ﬁbrin plays during
the initiation and progression of aortic aneurysms.12–14
In clinical practice, AAAs are currently diagnosed by
computed tomography angiography, magnetic resonance (MR)
angiography, or ultrasound. Besides the diameter, there is
currently no clinically established biomarker available to
improve the characterization of aneurysms and predict the
risk of rupture.6,15
In this study, we hypothesize that a ﬁbrin-speciﬁc molec-
ular MR probe allows for the detection of an early focal mural
hematoma associated with an aortic dissection, before the
dilation of the aorta. Additionally, early and late AAA-
associated thrombi can be differentiated based on their
relative ﬁbrin composition.
Methods
The data, analytic methods, and study materials will not be
made available to other researchers for purposes of repro-
ducing the results or replicating the procedure.
Animal Experiments
Homozygous C57BL/6J ApoE-knockout mice (male) were
acquired from Charles Rivers Laboratories (Edinburgh, UK).
Housing and care of animals and all the procedures performed
in this study were in accordance with the guidelines and
regulations of the United Kingdom Home Ofﬁce. Eight-week-
old mice were implanted with minipumps (Alzet model 2004,
Durect Corp). Angiotensin II was administered continuously by
subcutaneous infusion at a dose of 1 lg/kg1 per minute.9,16
magnetic resonance imaging (MRI) was performed at weeks 1,
2, 3, and 4 after the start of AngII infusion (n=8 per group,
Figure S1). Tissue was harvested for further processing each
week (n=8 per group, Figure S1). Sham-operated mice served
as the control group. These animals were also implanted with
minipumps but instead of angiotensin II, saline was infused for
4 weeks (sham-operated group, n=6). At each time point, 8
animals were scanned by MRI before and following the
administration of the control probe (gadopentetate dimeglu-
mine, Bayer Healthcare AG, Berlin) and additionally before and
following the administration of the ﬁbrin-speciﬁc molecular
probe. Within 48 hours, 2 imaging sessions were performed.
The ﬁrst imaging session included imaging before and
following the administration of 0.2 mmol/kg1 gadopentetate
dimeglumine (Gd-DTPA) to study the unspeciﬁc uptake in the
aortic wall. The second imaging session included imaging
before and following the administration of 10 lmol/kg1 of
an established ﬁbrin-speciﬁc molecular probe.17–20 Following
the two imaging sessions, mice were euthanitized for
histopathology, immunohistopathology, and inductively cou-
pled plasma mass spectroscopy (ICP-MS). Additionally, com-
petition experiments were performed (please see Data S1).
For each imaging session, animals were anesthetized by
intramuscular injection of a combination of medetomidine
(500 lg/kg1), fentanyl (50 lg/kg1), and midazolam (5 mg/
kg1). Following the imaging session, a combination of
Clinical Perspective
What Is New?
• The ﬁbrin-speciﬁc probe used in this study enables the
differentiation between acute and old abdominal aortic
aneurysms (AAA)-associated thrombi in a mouse model.
• Acute AAA-associated thrombi show a high-contrast
enhancement associated with a high content of ﬁbrin.
• Older AAA-associated thrombi show a low-contrast
enhancement associated with a low content of ﬁbrin.
What Are the Clinical Implications?
• Fibrin magnetic resonance imaging could provide a novel
in vivo biomarker to improve the risk stratiﬁcation of
patients with aortic aneurysms.
• The ﬁbrin-speciﬁc probe allowed an in vivo differentiation
between newly formed ﬁbrin-rich thrombi and advanced
remodeled thrombi.
• Such a parameter could be valuable for an improved
characterization of AAA-associated thrombi in vivo.
• This is especially relevant in the context of clinical studies
demonstrating that the D-dimer correlates with AAA growth.
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antidotes was administered to shorten anesthesia time. A
combination of atipamezole (2.5 mg/kg1), naloxone (1200
lg/kg1), ﬂumazenil (500 lg/kg1) was used.21 These
techniques have been previously described in detail.22,23
Following the last imaging session, terminal exsanguination by
anterior perfusion with phosphate buffered saline with a
pressure of 100 mm Hg. If vessel samples were used for
histology, this was followed by a perfusion with 10% formalin.
To allow for anatomic matching, the aorta was excised
including the right renal artery and last pair of intercostal
arteries.
In Vivo Molecular MR Imaging
Following the administration of the anesthesia, all animals
were positioned on a surface microscopy coil (4.7 cm, Philips
Healthcare, Best, Netherlands). For all imaging experiments, a
clinical 3T Achieva MR system was used (Philips Healthcare,
Best, Netherlands). The system was equipped with a clinical
gradient system (30 mT/m1, 200 mT/m1per millisecond).
Additionally, a dedicated software package for cardiac
imaging was available. For imaging, all animals were in a
supine position. Signal was received using a microscopy
single loop coil. To maintain the body temperature (37°C) of
animals during the imaging sessions, a dedicated MR-
compatible heating system was used (Model 1025, SA
Instruments Inc, Stony Brook, NY).
The imaging protocol included the following sequences.
First, a low-resolution scout scan (3-dimensional gradient
echo sequence) was used for an anatomic overview and to
localize the abdominal aorta. In the next step, a 2-
dimensional time-of-ﬂight (2D TOF) angiography was
performed in the transverse orientation for a speciﬁc
visualization of the abdominal aorta. Imaging parameters
included: imaging matrix=1609160, ﬁeld of
view=20920910 mm, slice thickness=0.5 mm, inplane
spatial resolution=0.390.3 mm (reconstructed 0.1390.13
mm), ﬂip angle=60°, repetition time (TR) sequence=37 ms
and echo time (TE) 7.7 ms. Based on the TOF angiography, a
maximum intensity projection (MIP) was automatically recon-
structed. Based on this MIP, with the visualization of the
intra-abdominal arteries, the following scans (T1 delayed-
enhancement MRI, T1 mapping) could be exactly planned in
the region of interest on the abdominal aorta. Prior to the T1
delayed-enhancement scan, a l\Look-Locker sequence (2-
dimensional) was planned on the aorta to determine the
nulling time (inversion time, TI) for blood. This approach is
comparable to the late enhancement imaging approach in the
myocardium. Imaging parameters for the Look-Locker were:
matrix=75975, ﬁeld of view=30 mm, slice thickness=2 mm,
inplane resolution=0.490.4, TR=19 ms, TE=8.6 ms, and ﬂip
angle=10°. The repetition time between inversion recovery
(IR) pulses was constant with 1 second. The following
imaging parameters were used for the inversion recovery
delayed-enhancement MRI scans (3D IR fast gradient echo
scans) for the visualization and quantiﬁcation of the molec-
ular probes. matrix=30930 mm, ﬁeld of view=30 mm, slice
thickness=0.5 mm, reconstructed slice thickness=0.25 mm;
40 slices were acquired, inplane spatial resolution=0.1 mm,
TR=28 ms, TE=8.2 ms, and ﬂip angle=30°. The repetition
time between IR pulses was constant with 1 second. Please
see Data S1 for additional information regarding T1 mapping
techniques and the in vivo competition experiments.
MR Image Analysis
Analysis of all resulting DICOM (Digital Imaging and Com-
munications in Medicine) images was performed using OsiriX
(version 7.1, OsiriX foundation). To localize the aortic wall
and aortic aneurysms, the high-resolution late-enhancement
images were automatically coregistered with the TOF images
based on the location data in the DICOM headers. All
morphometric measurements were performed on the high-
resolution late-enhancement images before and following the
administration of the control agent (gadopentetate dimeglu-
mine) and the ﬁbrin-speciﬁc molecular probe. For the
assessment of signal intensities, regions of interest were
measured as areas of signal enhancement on high-resolution
late-enhancement images in relation to the TOF images. For
these regions, the contrast-to-noise ratio (CNR) was calcu-
lated using the following formula: CNR=(combined vessel
wall and aneurysmal aortic tissue signalblood signal)/
noise. The signal of noise was determined as the standard
deviation measured in the air anterior to the aneurysmal
aortas.
Inductively Coupled Mass Spectroscopy
To measure the local concentration of the molecular probe,
ICP-MS was performed in a subgroup of aneurysmal aortic
tissue samples (n=3 per group).
For a reproducible analysis of the local gadolinium
concentration, tissue samples were digested overnight at
37°C using 70% nitric acid. For the ICP-MS analysis, tissue
samples were diluted with deionized water. For each analysis,
a standard curve was acquired for the concentration of
gadolinium.
Histologic and Immunohistochemical Analysis of
Aortic Aneurysms
Following the surgical removal of aortic aneurysms, tissues
were processed overnight for further histologic analysis. For
sectioning, aortic aneurysms were embedded in parafﬁn.
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Histologic sections (6 lm) were cut every 40 lm along the
aortic aneurysm. Sectioning was started from the proximal
end of the aneurysm. Sections were stained for Miller’s
Elastica van Gieson stain (EvG), Masson Trichrome (collagen),
and hematoxylin and eosin.
Immunohistochemical staining for ﬁbrin was performed
using a ﬁbrin-speciﬁc antibody (mouse anti-ﬁbrin-antibody, 1/
200 diluted, American Diagnostica, Stamford, CT, USA). Prior
to staining, sections were blocked for 10 minutes with DAKO
block at room temperature. Following incubation with the
primary antibody for 60 minutes, slides were washed with
Dulbecco’s phosphate-buffered saline at pH of 7.4 at room
temperature. In the next step, sections were stained for 60
minutes with a polyclonal rabbit anti-mouse IgG:Biotin (DAKO,
diluted 1/150) antibody. For signal generation extravidin
peroxidase (diluted 1/100) was used. The peroxidase activity
was measured using the Vector SG substrate kit (Vector
Laboratories, Peterborough, UK). For each histologic slide 100
lL of chromagen substrate was added for 15 minutes.
Histologic slides were then washed with Dulbecco’s phos-
phate-buffered saline, pH 7.4 (5 min/wash) 3 times, which
was followed by a rinse for 5 minutes in running tap water.
Nuclear Fast Red (Vector Laboratories) was used to counter-
stained tissue sections for 10 to 15 minutes. These
techniques have been described previously.24
Statistical Analysis
Values are expressed as meanstandard deviation. A Student
t test (two-tailed, unpaired) was used to compare continuous
variables. In case of more than 2 groups, statistical compar-
isons were performed by analysis of variance (ANOVA)
followed by the Bonferroni correction. A P value of 0.05 was
considered statistically signiﬁcant.
Results
Development of Aortic Aneurysms on MR
Angiography
In the control group (sham group, apoE/ mice) after 4
weeks of saline infusion using osmotic mini pumps, no aortic
dilation or development of aneurysms was observed (n=6,
Figures 1A, 2A, 2andB). In the aneurysm group, the contin-
uous infusion of 1 lg/kg1per minute angiotensin II via
osmotic minipumps resulted in the formation of suprarenal
aortic aneurysms (Figures 2 and 3). Different previous studies
have described this to be the prevalent site of aneurysm
formation in this mouse model.9,16,25 Following the initiation
of the angiotensin II infusion, animals were imaged after 1 to
4 weeks (n=8 per group). After 2 weeks of angiotensin II
infusion, a signiﬁcant increase (P<0.05) in abdominal aortic
areas was observed on the time of ﬂight angiography as well
as on ex vivo histological measurements (Figure 1A). The
aortic areas continued to increase during weeks 3 and 4
(P<0.05; Figure 1A). In vivo cross-sectional area measure-
ments based on the TOF angiography correlated strongly
(R2=0.83, y=0.96x+0.38) with the ex vivo area measurements
(Figure 1B). Area measurements on the TOF angiography
slightly overestimated the size of aortic aneurysms compared
with histology. Arterial rupture led to death through loss of
blood into the abdominal cavity before imaging in 3 mice.
These mice were excluded from the study and replaced.
Molecular Imaging of Thrombus Detection Using
the Fibrin-Speciﬁc Molecular Probe
Animals were imaged before and following the administration of
the nonspeciﬁc control agent (gadopentetate dimeglumine)
and the ﬁbrin-speciﬁc molecular probe. In both groups of mice
Figure 1. Development of aortic aneurysms in the ApoE/ mouse model. A, On in vivo MRI images, a gradual increase in aortic cross-
sectional areas was measured over the 4-week time course of angiotensin II infusion in the ApoE/ mouse model. A signiﬁcant (P<0.05)
increase was measured after 2 to 4 weeks compared with the control (sham) group. B, In vivo cross-sectional area measurements on the TOF
angiography signiﬁcantly correlated (P<0.05) with ex vivo area measurements on histology (EvG stain). Values are expressed as meansSD. MRI
indicates magnetic resonance imaging; TOF, time of ﬂight.
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(sham and Ang-II infusion), there was no signiﬁcant (P>0.05)
signal enhancement (Figures 2 and 3) of the aortic or
aneurysmal wall in both native MRI and after administration
of the nonspeciﬁc control agent (Gd-DTPA). In the sham-treated
mice there was also no signiﬁcant (P>0.05) signal enhance-
ment after the administration of the ﬁbrin-speciﬁc probe.
In vivo visualization of the aortic dissection site before
aortic dilation
In the aneurysm group, the continuous angiotensin II infusion
resulted in the dissection of the aortic wall with the rupture of
the elastic laminae in the tunica media. This was observed in
all stages of AAA development (Figure 2B2). The dissection of
the aortic wall was associated with the development of a
small intramural hematoma at the location where the elastic
laminae ruptured (Figure 2B3 and B4). Additionally, the
formation of a large extramural hematoma could be observed,
especially in advanced aortic aneurysms after 3 and 4 weeks
(Figure 3). At the early stage of aneurysm development, after
1 week of angiotensin II infusion, a strong focal signal could
be measured in the aortic wall following the administration of
the ﬁbrin-speciﬁc molecular probe. At this stage, no relevant
dilation of the aorta could be measured in vivo on the MR
angiogram. Corresponding histologic analysis conﬁrmed the
presence of an aortic dissection with the rupture of elastic
laminae and the formation of a small focal hematoma
(Figure 3B2–B4). Ex vivo staining for ﬁbrin conﬁrmed the
formation of a ﬁbrin-rich thrombus at that location (Fig-
ure 3B4). Corresponding to histopathology, the ﬁbrin-speciﬁc
molecular probe allowed the detection of the rupture site
before the dilation of the aorta (Figure 3A4–A6). In these
small focal hematoma, no relevant expression of elastin or
collagen was measured on histologic sections (Figure 3B2,
B3). This indicates that no tissue remodeling in the matrix of
the hematoma has occurred yet.
In vivo characterization of thrombi associated with the
formation of an aortic aneurysm
Following the infusion of angiotensin II, thrombi associated
with the development of aortic aneurysms were observed
(Figure 3A and 3B). In the early phases after 2 to 3 weeks,
these relatively large thrombi showed high CNRs following the
administration of the ﬁbrin-speciﬁc molecular probe (Fig-
ure 3A4–A6). This high signal correlated with a strong
staining for ﬁbrin on ex vivo immunohistopathology in these
thrombi (Figure 3B4). In the later phases of thrombus
development after 4 weeks, a signiﬁcant reduction in CNRs
was observed within the matrix of the thrombi following the
administration of the ﬁbrin-speciﬁc probe (Figure 3C4–C6).
Thrombi were still detectable; however, the signal from the
ﬁbrin-speciﬁc molecular probe was signiﬁcantly reduced. In
vivo signal measurements correlated with an overall
Figure 2. Assessment of a focal ﬁbrin-rich intramural hematoma before the dilation of the aorta by ﬁbrin MRI. A, On the TOF angiogram, a
nondilated aortic lumen without luminal irregularities can be appreciated in an ApoE/ mouse 1 week after continuous infusion of angiotensin II.
The red line indicates the alignment of in vivo MRI sequences and ex vivo histology. No signiﬁcant enhancement of the aorta was measured on
precontrast scans (A2) and following the administration of the nonspeciﬁc control agent (Gd-DTPA, A3). Following the administration of the ﬁbrin-
speciﬁc molecular probe, a strong focal enhancement was measured at the dissection side (A4–A6). On the EvG stain, the dissection of elastic
laminae can be clearly visualized on magniﬁed images (B2). In between the dissection, a ﬁbrin-rich mural hematoma can be visualized (B2–B4). It’s
a strong signal from the ﬁbrin that antibody was measured at the location of the intramural hematoma (B4). No relevant formation of elastin or
collagen ﬁbers was measured in the hematoma on histologic sections (B1–B3), indicating that no remodeling of the hematoma has occurred. aA
indicates abdominal aorta; Gd-DTPA, gadopentetate dimeglumine; MRI, magnetic resonance imaging; rRA, right renal artery; TOF, time of ﬂight.
DOI: 10.1161/JAHA.117.007909 Journal of the American Heart Association 5
Assessment of Thrombus Integrity in AAAs Using MRI Botnar et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 by guest on June 7, 2018
http://jaha.ahajournals.org/
D
ow
nloaded from
 
decreased expression of ﬁbrin within the thrombus on ex vivo
immunohistopathology. On the other hand, an increased
remodeling of the thrombus was observed with a signiﬁcantly
increased expression of collagen and elastic ﬁbers within the
matrix of the thrombus in all animals 3 to 4 weeks after
continuous Ang-II infusion (Figure 4B). Based on these
measurements, the ﬁbrin-speciﬁc molecular probe enabled
the differentiation between early thrombi formation and late-
stage remodel thrombi. As already suggested in previous
studies,9 the balance of extracellular matrix degradation and
formation in AAA-associated thrombi is an important factor in
the progression and outcome of aortic aneurysms.
Figure 3. Visualization of early and advanced/remodeled AAA-associated thrombi by ﬁbrinMRI. A and B, After 2weeks of angiotensin II infusion,
the formation of a suprarenal aortic aneurysm was observed on the TOF angiogram (A1). On precontrast scans and control scans with Gd-DTPA, no
signiﬁcant enhancement was measured. On the ﬁbrin MRI scan, a strong signal enhancement was measured at the location of the ﬁbrin-rich
thrombus (A4–A6, red arrows). Corresponding histology and immunohistochemistry show the formation of a fresh ﬁbrin-rich thrombuswith a strong
signal using the ﬁbrin-speciﬁc antibody. In areas adjacent to the thrombus, only a few elastin and collagen ﬁbers were observed (B1–B4), indicating
that no remodeling took place yet. C and D, After 4 weeks of angiotensin II infusion, the formation of advanced suprarenal aortic aneurysm was
observed on the TOF-angiogram (C1). On precontrast scans and control scans with Gd-DTPA, no signiﬁcant enhancement was measured. On the
ﬁbrin MRI scan, a weak-to-moderate signal enhancement was measured at the location of the ﬁbrin-rich thrombus (C4–C6, red arrows).
Corresponding histology and immunohistochemistry shows the formation of an advanced/remodeled thrombus with a weak signal using the ﬁbrin-
speciﬁc antibody. In areas adjacent to the thrombus, signiﬁcant expression of elastin and collagen ﬁbers was measured (D2–D4,), indicating that
remodeling took place. Compared with earlier stages of AAA formation (A+B), a strong increase in expression of elastin and collagen ﬁbers was
measured directly adjacent to the thrombus. aA indicates abdominal aorta; Gd-DTPA, gadopentetate dimeglumine; MRI, magnetic resonance
imaging; rRA, right renal artery; TOF, time of ﬂight.
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CNR and T1 Mapping
On vessel wall scans before the administration of the ﬁbrin-
speciﬁc molecular probe (precontrast) and after administra-
tion of Gd-DTPA, a relatively low CNR and R1 on T1 relaxation
maps in the aortic wall in all mice (sham and Ang-II infusion)
was measured (Figure 4A). Following the administration of the
ﬁbrin-speciﬁc molecular probe, a strong and signiﬁcant
(P<0.05) increase in CNR and R1 was measured at the aortic
dissection site before aortic dilation starting from 1 week of
Ang-II infusion. These in vivo measurements of CNR and R1
were in close and signiﬁcant (P<0.05) agreement with the
ex vivo quantiﬁcation of ﬁbrin density on immunohistochem-
istry sections. A minor, however not signiﬁcant (P>0.05),
progressive increase in CNR and R1 could also be observed
on precontrast and Gd-DTPA scans. This effect was due to the
minor intrinsic T1 shortening effect of intramural thrombi. No
signiﬁcant difference (P>0.05) in vessel wall enhancement
(CNR, R1) was detected between precontrast scans on day 2
and precontrast scans on day 1 (n=3 per group). Signal
effects from potentially remaining control agent (Gd-DTPA) in
the vascular wall could therefore be excluded.
Competition Experiments
The signal enhancement of precontrast scans in imaging
session 1 (CNR 3.90.6, Figure S2) did not differ (P>0.05)
from the signal enhancement of the other investigated
animals at the same time point in this study (4 weeks of
angiotensin II infusion). The administration of the gadolinium-
labeled ﬁbrin-speciﬁc molecular MR probe (EP2104R, 10
lmol/kg1) resulted in a marked increase of CNR (29.46.6,
P≤0.05), compared with the precontrast scan. Forty-eight
hours later at imaging session 2, initially a precontrast scan
was performed. The precontrast scan yielded a CNR of
4.11.3, which was not signiﬁcantly (P>0.05) different from
the precontrast scan during imaging session 1. In the next
step, the injection of 100 lmol/kg1 of the unlabeled imaging
probe peptide did not results in a signiﬁcant (P>0.05) increase
of CNR (4.21.7). In the ﬁnal step, the Gd-labeled ﬁbrin-
speciﬁc molecular MR probe (EP2104R, 10 lmol/kg1) was
administered. This resulted in a signiﬁcantly decreased
(P≤0.05) CNR compared with the probe injection during
session 1. No signiﬁcant difference (P>0.05) was found
between the precontrast scan during session 1 and session 2.
Gadolinium Concentration by Inductively Coupled
Mass Spectroscopy
The average concentration of gadolinium in the aneurysmal
aortic wall increased substantially as disease progressed from
the initial to advanced stages after 2 and 3 weeks. A
signiﬁcant decrease (P<0.05) in the gadolinium concentration
was observed after 4 weeks, compared with the 3-week
group. A signiﬁcant correlation of CNR (y=1.2x0.88,
Figure 4. In vivo assessment of ﬁbrin expression and time course of remodeling of AAA-associated thrombi regarding ﬁbrin, elastin, and
collagen ﬁbers. A, Comparison of average CNR values calculated from measurement on precontrast scans, control scans for Gd-DTPA, and ﬁbrin
MRI (n=8 per aneurysm group, n=6 sham group). A signiﬁcant and steady increase in CNR could be observed with increasing time of angiotensin
II infusion in weeks 1 to 3. In week 4, a signiﬁcant decrease on ﬁbrin MRI was measured compared with week 3, indicating the increased
remodeling of thrombi with a replacement of ﬁbrin. B, Graph demonstrating the time course of remodeling of AAA-associated thrombi from 1 to
4 weeks following angiotensin II infusion. In the control group (sham), no relevant expression of collagen or ﬁbrin was observed, only the normal
elastin expression in the elastic laminae of the aortic wall. After 1 week of angiotensin II infusion, a strong expression of ﬁbrin was observed in
thrombi, and no relevant expression of collagen or elastin was measured, compared to the sham group. The expression of collagen and elastin
gradually increased in weeks 2, 3, and 4, indicating the progressive remodeling of the thrombus. Fibrin expression also increased in weeks 2 and
3. Fibrin was, however, increasingly replaced by collagen and elastin in week 4. AAA indicates abdominal aortic aneurysm; CNR, contrast-to-
noise ratio; Gd-DTPA, gadopentetate dimeglumine; MRI, magnetic resonance imaging.
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R2=0.78, P<0.05) and R1 (y=0.31x0.75, R2=0.72, P<0.05)
with ex vivo measured gadolinium concentrations (ICP-MS)
was found.
Discussion
In this molecular MR imaging study, we report the in vivo
characterization of aortic aneurysms using a ﬁbrin-speciﬁc
molecular probe. The ﬁbrin-speciﬁc probe enabled the non-
invasive detection of the aortic dissection site before aortic
dilation by the visualization of the small ﬁbrin-rich hematoma
at the dissection site. In advanced aortic aneurysms, the
probe enabled the characterization of the relative ﬁbrin
expression within the matrix of AAA-associated thrombi. In
early thrombi, a strong in vivo signal and a high relative ﬁbrin
composition could be measured, which was conﬁrmed by
ex vivo analysis. In advanced thrombi, an increased remod-
eling of the matrix of the thrombus occurred and a relative
decrease in ﬁbrin expression was measured in vivo. These
changes could be visualized and quantiﬁed in vivo by the ﬁbrin
speciﬁc probe and ex vivo by immunohistopathology. Relative
changes in ﬁbrin composition of the thrombus at differ-
ent remodeling stages could therefore be monitored
noninvasively.
The signal enhancement measured by the ﬁbrin-speciﬁc
molecular probe differed markedly from the measurements
resulting from the commonly used control contrast agent, Gd-
DTPA, for which no signiﬁcant accumulation was measured. In
vivo aneurysmal CNR and R1 values following the administra-
tion of the ﬁbrin-speciﬁc probe were in good agreement with
ex vivo gadolinium concentrations as determined by ICP-MS.
There are various potential applications for a ﬁbrin-speciﬁc
probe in the context of AAAs. Unlike existing clinical
approaches, which are based on aneurysmal cross-sectional
area or diameter measurements for risk evaluation, ﬁbrin-
speciﬁc MRI enables the assessment of alterations within the
arterial wall at the molecular level.
In Vivo Visualization of Focal Hematoma
Associated With the Aortic Dissection Site Before
Aortic Dilation
Even though human AAAs represent a relatively frequent
vascular disease, their pathogenesis is not fully understood
yet. This is attributable to the difﬁculty in obtaining in vivo
tissue samples from aortic aneurysms. In contrast, it is
relatively easy to obtain tissue samples from atherosclerotic
plaques, eg, during carotid endarterectomy; therefore, sub-
stantially more data exist for the molecular characterization of
atherosclerosis. Previous studies investigating the develop-
ment of AAAs mainly relied on postmortem tissue samples
from patients who died of aortic aneurysm rupture. Typical
pathologic features of these late-stage or ruptured aneurysms
include adventitial hypertrophy, the accumulation of proin-
ﬂammatory cells and the high expression of extracellular
matrix proteins, such as collagen and elastic ﬁbers.26,27
Limited in vivo and ex vivo data are currently available
regarding the pathophysiologic processes in AAAs and the
composition of early-stage human AAAs. Different studies
have, however, indicated that aortic dissection, which
includes the rupture of elastic laminae, could be one of the
initiating events for the onset and progression of human
AAAs.9,28
In this experimental study, the initiating event for the
development of AAAs was the dissection or rupture of the
elastic laminae in the tunica media of the aorta. Subsequently,
a focal mural ﬁbrin-rich hematoma developed. This ﬁbrin-rich
hematoma could be clearly visualized using the ﬁbrin-speciﬁc
molecular probe. Other groups have also observed the
formation of a focal hematoma in this model.9 This is the
ﬁrst study to demonstrate that a ﬁbrin-speciﬁc probe allows
noninvasive detection of the aortic dissection sites on a
molecular level before a dilation of the aortic can be observed.
This observation is in line with measurements of the D-dimer
in patients. The D-dimer has even been proposed as a
parameter to rule out or conﬁrm an aortic dissection.29
Characterization of AAA Associated Thrombi
In patients with aortic aneurysms, an associated thrombus
usually develops. Following the development of mural
thrombi, the degree of remodeling of the matrix of the
thrombi is thought to be an important factor for a potential
further progression and rupture of aortic aneurysms.9 Differ-
ent studies have also shown that compensatory repair
mechanisms, which include the remodeling of the thrombus,
lead to a stabilization of the aneurysm and, in some cases, to
a reduction of size.30 These studies support the assumption
that compensatory remodeling mechanisms, which lead to a
relative decrease in ﬁbrin and relative increase in other
extracellular matrix proteins such as collagen and elastic
ﬁbers, play an important role in stabilizing the aneurysm and
the thrombus in patients with AAAs.11 Previous molecular
imaging studies have already investigated the potential of
thrombus imaging.31
In our study, a ﬁbrin-speciﬁc molecular probe enabled the
visualization and characterization of AAA-associated thrombi
in vivo. In the early phases of thrombus development, thrombi
are rich in ﬁbrin, which results from the cross-linking of
ﬁbrinogen to the ﬁbrin mesh. These fresh ﬁbrin-rich thrombi
could be detected with a high signal using the ﬁbrin-speciﬁc
molecular probe. In later stages with advanced remodeling of
the thrombus, the relative amount of ﬁbrin decreases, while
the relative amount of other extracellular matrix proteins,
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including collagen and elastin increases. This type of thrombi
could be detected with a signiﬁcantly reduced signal from the
ﬁbrin-speciﬁc probe.
The ﬁbrin-speciﬁc probe therefore allowed an in vivo
differentiation between newly formed ﬁbrin-rich thrombi and
advanced remodeled thrombi. Such a parameter could be
valuable for improved characterization of AAA-associated
thrombi in vivo. This is especially relevant in the context of
clinical studies demonstrating that the D-dimer correlates with
AAA growth.12 These results are in line with previous studies,
that have also reported a decrease in ﬁbrin probe binding to
older thrombi.32,33
Clinical Screening for and Characterization of
Aortic Aneurysms
In patients with suspected aortic aneurysms, computed
tomography angiography, magnetic resonance angiography,
and ultrasonography are the most frequently used imaging
techniques for the initial assessment and follow-up of
patients.34 It is currently recommended that small asymp-
tomatic AAAs (smaller than 3.5 cm) are closely monitored by
imaging. For larger AAAs (larger than 5.5 cm), endovascular
repair or aortic surgery is recommended.6 However, there is still
discussion regarding the optimalmanagement ofmedium-sized
AAAs (4–5.5 cm).6,15 This controversy reﬂects that novel
biomarkers are needed for an improved assessment of aortic
aneurysms. Currently, the only clinically established marker is
represented by the in vivo measurement of the aortic diameter.
Different studies have shown that this parameter has limita-
tions regarding the prognosis of progression and rupture.6,15
Regarding novel biomarkers for the assessment of AAAs,
the D-dimer has shown great promise. The D-dimer represents
a ﬁbrin fragment that is formed following endothelial damage
and the activation of repair processes. Different studies
showed a correlation between AAA diameter growth and D-
dimer values. The higher the plasma concentration of the D-
dimer, the faster the observed growth rate of the aneurysm
was.12 Additionally, a meta-analysis showed that D-dimer
concentration and aneurysm diameter have a strong linear
positive association.13 It was even suggested that a relative
cutoff value of D-dimer could be used to deﬁne the imaging
follow-up interval of aortic aneurysms.12 These observations
regarding the D-dimer were supported by a recent postmortem
study demonstrating that the majority of AAAs are associated
with nonocclusive murine thrombi and that ﬁbrin plays an
important role during the early thrombus formation and
advanced thrombus remodeling.14
In this context, a ﬁbrin-speciﬁc molecular probe could be
useful for further in vivo characterization of AAA-associated
thrombi remodeling. Thereby, it could provide information for
a more accurate risk stratiﬁcation of patients with AAAs.
Additionally, such a probe could be useful for the detection of
minor AAA-associated fresh hematomas in the aortic wall as
well as for the differentiation of early and old AAAs.
In the current clinical setting, molecular gadolinium-based
MR probes are not available. However, in the context of
atherosclerosis imaging, unspeciﬁc probes have shown
potential for an improved characterization of the composition
of the arterial wall.35
Translation of the Fibrin-Speciﬁc Molecular Probe
Into a Clinical Setting
MRI allows imaging of molecular probes with high spatial
resolution; it is, however, associated with a lower sensitivity for
probe detection compared with, eg, nuclear medicine tech-
niques such as positron emission tomography. To overcome
this limitation, a probe with a high relaxivity and a highly
expressed molecular target is important. Additionally, the
molecular probemust have a biokinetic proﬁle for fast excretion
of the probe, so imaging can be performed shortly after
administration. The unbound probe should have a substantially
lower relaxivity compared with the bound probe to minimize
signal from unspeciﬁc binding. The ﬁbrin-speciﬁc molecular
probe used in this study was developed to fulﬁll these
properties. The molecular probe is composed of a small peptide
with fast-binding kinetics. It is linked to four gadolinium
chelates to maximize the relaxivity, if the probe is bound to its
target. A high longitudinal relaxivity for the bound probe of
64.32.8 mmol/L1per second1 was reported at 3 T.24
Because of the high relaxivity of the probe, a relatively low dose
(10 lmol/kg1) was administered. The used dose was
comparable to the applied dose in large animal models and
the successful clinical feasibility trial.18,36–38 The probability of
gadolinium-induced toxicity is therefore reduced as such a low
dose is used. This is especially relevant in the light of recent
ﬁndings regarding nephrogenic systemic ﬁbrosis.39
For the in vivo characterization of ﬁbrin in aortic
aneurysms, it is an important safety consideration that the
administered probe does not interfere with the clotting
cascade or other targets for therapeutic intervention. The
ﬁbrin-speciﬁc probe used in this study was designed to
selectively bind ﬁbrin and not its precursor, ﬁbrinogen.40,41
Different ﬁbrin-targeted nanoparticles have also been applied
for the experimental in vivo visualization of thrombi by other
groups.42,43 The probe used in our study is the only one that
has already been successfully tested in a clinical setting.18
Limitations
The main difference between the experimental model used in
this study, compared with human AAAs, is the different
anatomic locations where the aneurysm develops. In patients,
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AAAs develop in most cases in the infrarenal part of the aorta.
In the ApoE/ mouse model used in this study, AAAs
develop in the suprarenal part of the aorta.9,16,44 The exact
mechanism responsible for this difference has not been
elucidated yet. It has been hypothesized that the difference in
blood pressure/hemodynamics and regional differences in
the composition of the aortic wall might be responsible for
this difference.45 Compared with the different experimental
animal models of AAAs, the ApoE/ mouse model used in
this study has the advantage that no surgical intervention is
needed. AAAs develop spontaneously as a result of the
continuous angiotensin II infusion with the associated
increase blood pressure.
Conclusion
This study demonstrates that ﬁbrin-speciﬁc molecular MR
imaging enables the in vivo characterization of AAAs. The
early formation of a focal mural hematoma, associated with
the aortic dissection, could be detected before the dilation of
the aorta. Additionally, changes in the ﬁbrin composition of
AAA-associated thrombi could be quantiﬁed and enable a
differentiation between early ﬁbrin-rich and advanced remod-
eled stable thrombi. Fibrin MRI could therefore provide a novel
in vivo biomarker to improve the risk stratiﬁcation of patients
with aortic aneurysms.
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Supplementary Methods 
 
In vivo molecular MR imaging 
Following the 3D IR fast gradient echo scans, a quantitative T1 mapping sequence (3D) was 
acquired. Part of the sequence are two inversion-recovery prepared modified Look-Locker 
‘trains’.1, 2 Each trains is initiated by a non-selective IR pulse (inversion pulse) that is defined by 
a specific initial IR time (inversion time, 12, 73ms). The IR pulse is followed by eight segmented 
readouts for the reconstructed eight individual images. The inversion times are defined as the 
time from the center of the preparation pulse to the acquisition of the k0 profile in k space. A 
delay of 500ms is inserted in-between each image acquisition to minimize potential saturation 
effects and to enable an accurate quantification of long T1 times. Imaging parameters of the T1 
mapping sequences were:  
Matrix = 180 x 151, field of view = 18 x 36 mm, voxel size 0.2 x 0.2 x 0.5 mm, repetition time 
(TR) = 9.8 ms, echo time (TE) = 5.1 ms, acquisition window = 157 ms, flip angle = 8°. A set of 
16 source images resulted from the two imaging trains. T1 values were calculated pixel by pixel 
using a three-parameter curve fitting technique of the longitudinal magnetization Mz(TI), which 
included a T1 correction:3 
Mz(TI)=M0*- (M0+M0*)
e-(TI((1/T1)-(1/TR)ln(cos alpha)))
 
 
T1 then can be calculated as:4 
T1=T1* (((M0+M0*)/(M0*)) – 1)
 
M0 represents the equilibrium magnetization. The longitudinal magnetization is sampled during 
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 its recovery. Therefore, the relaxation process is influenced by the constant application of RF-
pulses which results in the assessment of an apparent relaxation time T1* (T1*<T1; R1=1/T1; 
1/T1*= T/T1+1/T1LookLocker) and a reduction in the equilibrium magnetization M0*.  
Following the completion of MR scanning, mice were euthanized by dislocation of the neck. 
Tissues were then harvested for further processing. These techniques have been previously 
described in 5, 6. 
 
Aortic aneurysm morphometry 
The suprarenal aorta was excised including the last pair of intercostal artery and the right renal 
artery. Landmarks for co–registration were the left renal artery and the last pair of intercostal 
artery. A time–of–flight (TOF) angiogram was always acquired before planning of the DE–MRI 
(delayed enhancement magnetic resonance imaging) imaging slices. Based on the 3D maximum 
intensity projection (MIP) reconstructed from the TOF angiograms, high–resolution DE–MRI 
imaging slices could be planned exactly perpendicular to the course of the aorta. All 
morphometric analyses were made on elastin–stained sections. Morphometry was performed 
using ImageProPlus software (ImageProPlus, MediaCybernetics). The areas enclosed by the 
adventitia and the lumen were recorded. %EvG stain per adventitial area was assessed using 
ImageProPlus. Segmentation of elastic fibers was based on the color profile of the elastic fibers 
in the media of the vessel wall on the EvG stained section. These techniques have been 
previously described in 5. 
 
Competition experiments: 
In vivo competition experiments (supplementary figure 2) were performed in ApoE-/- mice 
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 following the four-week infusion of angiotensin-II (Ang-II, 1 microgram kg-1 min). During 
imaging session one initially a precontrast scan, prior to the administration of the fibrin specific 
probe, was performed. Following the precontrast scan, the fibrin specific molecular MR probe 
(EP2104R, 10 µmol kg–1) was administered and imaging was performed using a T1 delayed 
enhancement MRI sequence. 48 hours later, imaging session two was performed. Initially a 
precontrast scan was acquired to confirm that no residual binding is present. In the next step, 100 
µmol kg-1 of the unlabeled imaging probe peptide were administered. Subsequently, another T1 
delayed enhancement MRI was performed to exclude an increase in signal enhancement. 
Following this scan, the Gd-labeled fibrin specific molecular MR probe (EP2104R, 10 µmol kg–
1) was administered and another T1 delayed enhancement MRI was performed.  
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 Figure S1. Organization of study with time-course of in vivo imaging and ex vivo tissue 
analysis.  
 
 
 
Setup and time-course of the animal experiments indicating the different timepoints at which in 
vivo MR imaging and ex vivo tissue analysis was performed. It was demonstrated by different 
previous studies that media dissection is the initial event in AAA formation in the animal model 
used7. In advanced stages of AAA development, the fibrin rich thrombus gets increasingly 
remodeled and stabilized with extracellular matrix proteins including collagen and elastin.  
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 Figure S2. In vivo competition experiments in ApoE-/- mice with aortic aneurysms. 
 
 
The signal enhancement of precontrast scans in imaging session one did not differ from the signal 
enhancement of the other investigated animals at the same time point in this study (4 weeks of 
angiotensin II infusion). The administration of the gadolinium labeled fibrin specific molecular MR probe 
resulted in a marked increase of, compared to the precontrast scan. 48 hours later at imaging session two, 
initially a precontrast scan was performed. The precontrast scan yielded a CNR which was not 
significantly different from the precontrast scan during imaging session one. In the next step, the injection 
of the unlabeled imaging probe peptide did not result in a significant increase of CNR. In the final step, 
the Gd-labeled fibrin specific molecular MR probe (EP2104R) was administered. This resulted in a 
significantly decreased CNR compared to the probe injection during session one. No significant 
difference was found between the precontrast scan during session one and session two. 
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